The present study highlighted increased BMI, high fasting blood glucose levels, as well as decreased adiponectin concentrations as clinical and biological risk factors of inflammation in a sample of patients with T2DM. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.